Elisabeth Simader
-
- Immunotherapy and Immune Responses 4
- IL-33, ST2, and ILC Pathways 3
- Ophthalmology top 10%
- Glaucoma and retinal disorders 3
-
- SARS-CoV-2 and COVID-19 Research 5
-
- Heat shock proteins research 5
-
- Systemic Lupus Erythematosus Research 4
- Rheumatoid Arthritis Research and Therapies 4
-
- Peripheral Neuropathies and Disorders 3
- Co-authors
- Hendrik Jan AnkersmitMichael MildnerLucian BeerMatthias ZimmermannФлориан ГруберDenise TraxlerMariann GyöngyösiChristian Gabriel
- Cited by
- GeneticsRehabilitationImmunology
In The Last Decade
Elisabeth Simader
27 papers receiving 368 citations
Peers
Comparison fields: 5 of 75
- Genetics 46
- Rehabilitation 26
- Immunology 79
- Ophthalmology 31
- Cancer Research 47
Countries citing papers authored by Elisabeth Simader
This map shows the geographic impact of Elisabeth Simader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Simader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Simader more than expected).
Fields of papers citing papers by Elisabeth Simader
This network shows the impact of papers produced by Elisabeth Simader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Simader. The network helps show where Elisabeth Simader may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Simader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 12 | |
| 15 | 2019 | 26 | |
| 16 | 2018 | 35 | |
| 17 | 2018 | 10 | |
| 18 | 2017 | 15 | |
| 19 | 2015 | 98 | |
| 20 | 1994 | 4 |
About Elisabeth Simader
Elisabeth Simader is a scholar working on Immunology, Rheumatology, Ophthalmology, Immunology and Allergy and Rehabilitation, having authored 31 papers that have together received 369 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Heat shock proteins research (5 papers), Immunotherapy and Immune Responses (4 papers), Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Peripheral Neuropathies and Disorders (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and Glaucoma and retinal disorders (3 papers). The work is most often cited by research in Genetics (46 citations), Rehabilitation (26 citations), Immunology (79 citations), Ophthalmology (31 citations) and Cancer Research (47 citations). Elisabeth Simader has collaborated with scholars based in Austria, Germany and Slovenia. Frequent co-authors include Hendrik Jan Ankersmit, Michael Mildner, Lucian Beer, Matthias Zimmermann, Флориан Грубер, Denise Traxler, Mariann Gyöngyösi, Christian Gabriel, Sibylle Madlener and Ingrid Kreissig. Their work appears in journals such as Annals of the Rheumatic Diseases, Scientific Reports, Journal of Autoimmunity, Clinica Chimica Acta and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.